Avidity Biosciences CFO Divests $3.7 Million in Company Stock
Michael F. MacLean, the Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), has made headlines with a significant stock transaction. On June 12, 2024, MacLean sold 104,245 shares of the company's common stock, generating a total transaction value exceeding $3.7 million. The shares were sold at a weighted average price of $35.7153, with individual transaction prices ranging from $34.51 to $37.57.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
